#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA


March 26, 2020 — The Radiological Society of North America (RSNA) has published an expert consensus statement on reporting chest computed tomography (CT) findings related to COVID-19. The statement, published in Radiology: Cardiothoracic Imaging, is endorsed by the RSNA, the American College of Radiology and the Society of Thoracic Radiology.

“We believe it is important to provide radiologists and referring providers guidance and confidence in reporting these findings and a more consistent framework to improve clarity,” said Suhny Abbara M.D., editor of Radiology: Cardiothoracic Imaging and professor of radiology and chief of the Cardiothoracic Imaging Division at UT Southwestern Medical Center in Dallas, Texas. “Clear evidence-based communication among health care providers, including radiologists, is imperative to improving patient care during this pandemic.”

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become increasingly prevalent worldwide, reaching a pandemic stage in March 2020.

While routine screening CT for the identification of COVID-19 pneumonia is currently not recommended by most radiology societies, the number of CTs performed in patients under investigation for COVID-19 has increased. Some patients may have incidentally detected findings that could be attributable to COVID-19 pneumonia, requiring radiologists to decide whether to mention COVID-19 specifically as a differential diagnostic possibility.

COVID-19 pneumonia, which has a high mortality rate among the elderly and those with diabetes, hypertension, and other comorbidities, is spreading rapidly in communities. As a result, including “COVID-19” frequently in radiology report could trigger a cascade of events including infection control measures and anxiety for both the clinician and patient. Importantly, CT imaging features of COVID-19 can overlap significantly with other causes of acute lung injury and pneumonia, complicating interpretations.

The consensus statement, developed by experts at nine U.S. academic medical centers, aims to help radiologists recognize findings of COVID-19 pneumonia and provide guidance on reporting CT findings potentially associated with COVID-19, including standardized language to reduce reporting variability.

Standardized reporting language will improve communication with referring providers and has the potential to enhance efficiency and reduce anxiety in management of patients during the pandemic.

The paper discusses the potential role of CT in COVID-19, parameters for structured reporting, and the pros, cons and limitations of adopting this strategy.

Because practice patterns may vary by institution, the document is meant to serve as a guide. The authors recommend that radiologists consult with clinical colleagues at their institutions to establish a consensus reporting approach.

For more information: www.rsna.org

Related Coronavirus Content:

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now